Treatment of Evans' syndrome with human intravenous immunoglobulin and leflunomide in a diabetic dog

Journal of the American Animal Hospital Association

Volumn 45, Issue 3, 2009, Pages 147-150

  Bianco, Domenico ^a   Hardy, Robert M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; ISOXAZOLE DERIVATIVE; LEFLUNOMIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; DIABETES MELLITUS; DOG; DOG DISEASE; DRUG COMBINATION; FEMALE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; DIABETES MELLITUS; DOG DISEASES; DOGS; DRUG COMBINATIONS; FEMALE; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TREATMENT OUTCOME;

EID: 68149157318     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0450147     Document Type: Article

References (26)

1. Jackson ML, Kruth SA. Immune-mediated hemolytic anemia and thrombocytopenia in the dog: a retrospective study of 55 cases diagnosed from 1969 through 1983 at the Western College of Veterinary Medicine. Can Vet J 1985;26:245-250.
2. McCullough S. Immune-mediated hemolytic anemia: understanding the nemesis. Vet Clin North Am Small Anim Pract 2003;33:1295-1315.
3. Lewis DC, Meyers KM, Callan MB, et al. Detection of plateletbound and serum platelet-bindable antibodies in the diagnosis of canine ITP. J Am Vet Med Assoc 1995;206(1):47-52.
4. Kristensen AT, Weiss DJ, Klausner JS, et al. Detection of antiplatelet antibodies with a platelet immunofluorescence assay. J Vet Intern Med 1994;8(1):36-39.
5. Wilkerson MJ, Shuman W, Swist S, et al. Platelet size, platelet surface-associated IgG, and reticulated platelets in dogs with immunemediated thrombocytopenia. Vet Clin Pathol 2001;30(3):141-149.
6. Scott MA, Kaiser L, Davis JM, et al. Development of a sensitive immunoradiometric assay for detection of platelet surface-associated immunoglobulins in thrombocytopenic dogs. Am J Vet Res 2002;63(1):124-136.
7. Behrend EN, Kemppainen RJ. Glucocorticoid therapy: pharmacology, indications, and complications. Vet Clin North Am Small Anim Pract 1997;27:187-213.
8. Huang HP, Yang HL, Liang SL, et al. Iatrogenic hyperadrenocorticism in 28 dogs. J Am Anim Hosp Assoc 1999;35(3):200-207.
9. Jeffers JG, Shanley KJ, Schick RO. Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy. J Am Vet Med Assoc 1991;199(1):77-80.
10. Weinkle TK, Center SA, Randolph JF, et al. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). J Am Vet Med Assoc 2005;226(11):1869-1880.
11. Mason N, Duval D, Shofer FS, et al. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial. J Vet Intern Med 2003;17(2):206-212.
12. Feldman BF, Handagama P, Lubbernik BB. Splenectomy as adjunctive therapy for immune-mediated thrombocytopenia and hemolytic anemia in the dog. J Am Vet Med Assoc 1985;187(6):617-619.
13. Kellerman DL, Bruyette DS. Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs. J Vet Intern Med 1997;11(6):327-332.
14. Scott-Moncrieff JC, Reagan WJ, Snyder PW, et al. Intravenous administration of human immune globulin in dogs with immunemediated hemolytic anemia. J Am Vet Med Assoc 1997;210(11):1623-1627.
15. Scott-Moncrieff JC, Reagan JW, Glickman LT, et al. Treatment of nonregenerative anemia with human γ-globulin in dogs. J Am Vet Med Assoc 1995;206(12):1895-1900.
16. Bianco D, Armstrong PJ, Washabau RJ. Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs. J Vet Intern Med 2007;21(4):694-699.
17. Scott-Moncrieff JC, Reagan WJ. Human intravenous immunoglobulin therapy. Semin Vet Med Surg 1997;12(3):178-185.
18. Nuttall TJ, Malham T. Successful intravenous human immunoglobulin treatment of drug-induced Steven-Johnson syndrome in a dog. J Sm Anim Pract 2004;45(7):357-361.
19. Trotman TK, Phillips H, Fordyce H, et al. Treatment of severe adverse cutaneous drug reactions with human intravenous immunoglobulin in two dogs. J Am Anim Hosp Assoc 2006;42(4):312-320.
20. Rahilly LJ, Keating JH, O'Toole TE. The use of intravenous human immunoglobulin in treatment of severe pemphigus foliaceus in a dog. J Vet Intern Med 2006;20(6):1483-1486.
21. Reagan WJ, Scott-Moncrieff JC, Christian J, et al. Effects of human intravenous immunoglobulin on canine macrophages and lymphocytes. Am J Vet Res 1998;59(12):1568-1574.
22. Gregory CR, Stewart A, Sturges B, et al. Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy. Transplant Proc 1998;30(8):4143-4148.
23. Gregory CR, Silva HT, Patz JD, et al. Comparative effects of malononitriloamide analogs of leflunomide on whole blood lymphocytes stimulation in humans, rhesus macaques, cats, dogs, and rats. Transplant Proc 1998;30(4):1047-1048.
24. McChesney LP, Xiao F, Sankary HN, et al. An evaluation of leflunomide in the canine renal transplantation model. Transplantation 1994;57(12):1717-1722.
25. Carr AP, Panciera DL, Kidd L. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs. J Vet Intern Med 2002;16(5):504-509.
26. Peikes H, Morris DO, Hess RS. Dermatologic disorders in dogs with diabetes mellitus: 45 cases (1986-2000). J Am Vet Med Assoc 2001;219(2):203-208.